Literature DB >> 16150395

Managing advanced-stage cervical cancer.

D Allen1, K Narayan.   

Abstract

The current staging methods and the definition of advanced cervical cancer are discussed. The clinical International Federation of Gynaecology and Obstetrics (FIGO) staging system has been found to be inaccurate and this limits treatment planning. More accurate management could be based on surgicopathological features of the tumour. However, the latest imaging techniques have the potential to give us this information in a non-invasive way. To deliver optimal treatment in advanced cervical cancer, we need to optimize the way we categorize the prognostic groups. Accurately delineating the extent of the disease will potentially minimize treatment morbidity and improve survival. The techniques of chemoradiation are also discussed in detail.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150395     DOI: 10.1016/j.bpobgyn.2005.03.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Kenji Kanenishi; Masami Ohno; Toshiyuki Hata; Yoshio Kushida; Reiji Haba; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-18       Impact factor: 9.236

2.  Influence of metal of the applicator on the dose distribution during brachytherapy.

Authors:  Chin-Hui Wu; An-Cheng Shiau; Yi-Jen Liao; Hsin-Yu Lin; Yen-Wan Hsueh Liu; Shih-Ming Hsu
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

3.  HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.

Authors:  Chin-Hui Wu; Yi-Jen Liao; An-Cheng Shiau; Hsin-Yu Lin; Yen-Wan Hsueh Liu; Shih-Ming Hsu
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.